It was reported that expression of BRCA1 and BRCA2, both let-7a targets, was down-regulated after delivery of magnetic core–shell nanoparticle (MCNP)/let-7a constructs to breast cancer cells. This evidence concerns the gene BRCA2 and breast carcinoma.